MANJUSHA GAGLANI to Respiratory Syncytial Viruses
This is a "connection" page, showing publications MANJUSHA GAGLANI has written about Respiratory Syncytial Viruses.
Connection Strength
0.108
-
RSV Vaccine Effectiveness Against Hospitalization Among US Adults Aged 60 Years or Older During 2 Seasons. JAMA. 2025 Oct 28; 334(16):1442-1451.
Score: 0.057
-
Severity of Respiratory Syncytial Virus vs COVID-19 and Influenza Among Hospitalized US Adults. JAMA Netw Open. 2024 04 01; 7(4):e244954.
Score: 0.051